LEXICON
No.84 October 3, 2011

Hemoglobin A1c (HbA1c)
ヘモグロビンA1c
HbA1c determined by the NGSP (National Glycohemoglobin Standardization Program) method
NGSP値 (HbA1c (NGSP))
HbA1c determined by the JDS (Japan Diabetes Society) method
JDS値 (HbA1c (JDS; 日本糖尿病学会))

Hemoglobin A1c (HbA1c値) is a kind of glycated hemoglobin (糖化ヘモグロビン) measured to determine the average plasma glucose concentration over a prolonged period of time. The amount of HbA1c as a percentage of the total amount of hemoglobin is used as...

To read the full story

LEXICON

By Sakura Kono

Japan’s general trading houses are steadily becoming a force to be reckoned with in the pharmaceutical industry — and not…

A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…

Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…

By Philip Carrigan

In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…

By Ken Yoshino

The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…